Close this search box.

Clinical Trial: SWOG S1216

SWOG S1216

Status: Closed

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer

S1216 has met its accrual goal and is permanently closed to accrual effective July 15, 2017 at 11:59 p.m. Pacific.